Coloplast A/S (CLPBY)
12.41
+0.36
(+2.99%)
USD |
OTCM |
May 03, 16:00
Coloplast Market Cap: 27.90B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 27.90B |
| May 02, 2024 | 27.09B |
| May 01, 2024 | 27.46B |
| April 30, 2024 | 27.41B |
| April 29, 2024 | 28.10B |
| April 26, 2024 | 28.01B |
| April 25, 2024 | 28.28B |
| April 24, 2024 | 29.97B |
| April 23, 2024 | 29.81B |
| April 22, 2024 | 29.11B |
| April 19, 2024 | 29.16B |
| April 18, 2024 | 28.93B |
| April 17, 2024 | 29.14B |
| April 16, 2024 | 29.38B |
| April 15, 2024 | 29.23B |
| April 12, 2024 | 29.16B |
| April 11, 2024 | 30.46B |
| April 10, 2024 | 29.87B |
| April 09, 2024 | 29.92B |
| April 08, 2024 | 30.01B |
| April 05, 2024 | 30.10B |
| April 04, 2024 | 29.92B |
| April 03, 2024 | 30.10B |
| April 02, 2024 | 29.95B |
| April 01, 2024 | 30.55B |
| Date | Value |
|---|---|
| March 28, 2024 | 30.42B |
| March 27, 2024 | 30.46B |
| March 26, 2024 | 30.37B |
| March 25, 2024 | 30.44B |
| March 22, 2024 | 30.35B |
| March 21, 2024 | 30.42B |
| March 20, 2024 | 30.80B |
| March 19, 2024 | 30.28B |
| March 18, 2024 | 30.62B |
| March 15, 2024 | 30.91B |
| March 14, 2024 | 30.80B |
| March 13, 2024 | 31.62B |
| March 12, 2024 | 32.15B |
| March 11, 2024 | 31.86B |
| March 08, 2024 | 31.93B |
| March 07, 2024 | 31.75B |
| March 06, 2024 | 31.00B |
| March 05, 2024 | 30.31B |
| March 04, 2024 | 30.73B |
| March 01, 2024 | 30.17B |
| February 29, 2024 | 30.10B |
| February 28, 2024 | 29.70B |
| February 27, 2024 | 30.22B |
| February 26, 2024 | 30.24B |
| February 23, 2024 | 30.01B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
20.76B
Minimum
Oct 10 2022
40.09B
Maximum
Aug 05 2021
29.10B
Average
28.66B
Median
Mar 25 2020
Market Cap Benchmarks
| Genmab A/S | 19.22B |
| Ascendis Pharma A/S | 7.767B |
| Galecto Inc | 18.98M |
| Evaxion Biotech AS | 20.60M |
| IO Biotech Inc | 97.50M |
Market Cap Related Metrics
| PE Ratio | 38.36 |
| PS Ratio | 7.423 |
| PEG Ratio | 7.377 |
| Price to Book Value | 12.42 |
| Price to Free Cash Flow | 43.64 |
| Price | 12.41 |
| Earnings Yield | 2.61% |
| PEGY Ratio | 5.016 |
| Operating PE Ratio | 26.92 |
| Normalized PE Ratio | 38.48 |